Grace Therapeutics, INC. (GRCE) — 10-K Filings
All 10-K filings from Grace Therapeutics, INC.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Grace Therapeutics Maintains Nasdaq Listing, Compliance Status
— Jun 23, 2025 Risk: medium
Grace Therapeutics, Inc. (GRCE) reported its 10-K for the fiscal year ended March 31, 2025, indicating its status as a non-accelerated filer and a smaller repor -
Acasti Pharma Files 2024 10-K
— Jun 21, 2024 Risk: medium
Acasti Pharma Inc. filed its 10-K for the fiscal year ending March 31, 2024, reporting on its financial condition and business operations. The company, incorpor
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX